This inventor holds 1 USPTO granted patent. Top assignees: Children's Medical Center Corporation, Harvard College, The Brigham and Women's Hospital, Inc.. Active years: 2017.
Company Filing History:
1 out of 1,072 
1 out of 3,069 
1 out of 1,422 
Years Active: 2017
Title: Si-yi Ryan Lee: Innovator in Sickle Cell Disease Diagnosis
Introduction
Si-yi Ryan Lee is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of sickle cell disease. His innovative approach has the potential to improve patient outcomes and streamline diagnostic processes.
Latest Patents
Si-yi Ryan Lee holds a patent for a groundbreaking invention titled "Multiphase systems for diagnosis of sickle cell disease." This patent describes an aqueous multi-phase system that includes two or more phase-separated phases. The first aqueous phase contains a first phase component with a density between about 1.025 g/cm and about 1.095 g/cm, while the second aqueous phase includes a second phase component with a density between about 1.100 g/cm and about 1.140 g/cm. The first density is lower than the second density, and each phase component includes at least one polymer. This innovative system aims to enhance the accuracy and efficiency of diagnosing sickle cell disease.
Career Highlights
Throughout his career, Si-yi Ryan Lee has worked with prestigious institutions such as Harvard College and Children's Medical Center Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
Si-yi Ryan Lee has collaborated with notable colleagues, including Caeul Lim and Manoj T Duraisingh. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Si-yi Ryan Lee is a prominent inventor whose work in the diagnosis of sickle cell disease showcases his commitment to innovation in medical technology. His patent and collaborations reflect his dedication to improving healthcare outcomes through scientific advancements.